论文信息 - Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study - 字舞流文

Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study

S. Li | C. Guo | L. Liu | G. Wang | J. Zhang | K. Zhao

[1] W. Klepetko,et al. Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study , 2022, ESMO open.

[2] W. Vigneswaran,et al. Neoadjuvant Chemotherapy vs Chemoradiation followed by Sleeve Resection for Resectable Lung Cancer. , 2022, The Annals of thoracic surgery.

[3] S. Broderick,et al. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy. , 2016, The Annals of thoracic surgery.

[4] Y. Nishimura,et al. A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903) , 2012, Cancer.